Showing results (1-10 of 361) with videos related to
Sort By:
Pageof 37
Expert Review of Hematology|April 30, 2021
Clinical challenges and promising therapies for chemotherapy-induced thrombocytopeniaHanny Al-Samkari, Gerald A SoffCancer Medicine|August 13, 2024
Romiplostim in chemotherapy-induced thrombocytopenia: A review of the literatureGerald A Soff, Hanny Al-Samkari, Avi Leader, et al.Seminars in Thrombosis and Hemostasis|February 28, 2022
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for CliniciansHanny Al-SamkariHematology. American Society of Hematology. Education Program|December 9, 2022
Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problemHanny Al-SamkariBlood|November 10, 2020
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of careHanny Al-SamkariBlood Reviews|November 1, 2023
Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonistsHanny Al-SamkariResearch and Practice in Thrombosis and Haemostasis|September 2, 2025
Should thrombopoietin receptor agonists be used for chemotherapy-induced thrombocytopenia?Hanny Al-SamkariPediatric Blood & Cancer|November 14, 2024
Mitapivat for Acquired Pyruvate Kinase DeficiencyHanny Al-SamkariAmerican Journal of Hematology|August 6, 2024
2025 update on clinical trials in immune thrombocytopeniaHanny Al-SamkariPageof 37